Effects of Light Emitting Diodes (LED) Therapy in Rugby Athletes
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03728439 |
|
Recruitment Status :
Completed
First Posted : November 2, 2018
Last Update Posted : July 13, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Phototherapy | Device: LED before Device: LED interval Device: LED after | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 21 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Intervention Model Description: | This is a randomized crossover (crossover) trial. Participants will be randomized to not receive LED (CO) or have the application of LED therapy at three different times: before (Lpré), in the interval (Lin) and after (Lpós) of the Bangsbo and YoyoIR1 performance tests. At 7, 14 and 21 days after the initial tests, the same test and evaluation protocol will be performed. In addition, 48 hours after each test protocol, functional tests, recovery questionnaire and blood collection will be applied for analysis of creatine kinase. |
| Masking: | Double (Investigator, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Analysis of Delayed Onset Muscle Soreness, Functional Performance, Inflammatory and Ergogenic Response of Light Emitting Diodes (LED) Therapy in Rugby Athletes |
| Actual Study Start Date : | February 1, 2019 |
| Actual Primary Completion Date : | September 10, 2019 |
| Actual Study Completion Date : | November 30, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Before
LED applications at the beginning, with a dose of 8 J/cm2, will be performed shortly after the blood collections, with a maximum period of 10 minutes, in which the participants of the other groups should remain in rest passive. At the end of these 10 minutes, a 5 minute warm up will be performed and then the tests will be started.
|
Device: LED before
Phototherapy will be applied through LED therapy equipment, with 15 light emitting diodes that produce 8 joules (J) per diode and 120 joules in total. The muscular regions irradiated will be the quadriceps, hamstrings and triceps sural, with two points of application in each muscle group. |
|
Experimental: Interval
The LED therapy applied in the tests interval will be performed after the first block of tests, with a maximum duration of 10 minutes and dose of 8 J/cm2. Then the second block of maximum tests will be performed.
|
Device: LED interval
Phototherapy will be applied through LED therapy equipment, with 15 light emitting diodes that produce 8 joules per diode and 120 joules in total. The muscular regions irradiated will be the quadriceps, hamstrings and triceps sural, with two points of application in each muscle group. |
|
Experimental: After
LED applications at the end will be performed 10 minutes after the second battery of tests, also with 8 J/cm2 and in the same muscles irradiated in the other moments of application.
|
Device: LED after
Phototherapy will be applied through LED therapy equipment, with 15 light emitting diodes that produce 8 joules per diode and 120 joules in total. The muscular regions irradiated will be the quadriceps, hamstrings and triceps sural, with two points of application in each muscle group. |
|
No Intervention: Baseline
On that day, participants will not receive any intervention.
|
- Changes in creatine kinase [ Time Frame: Before, immediately after and after 48 hours. ]Analysis of inflammatory and cellular lesion responses with creatine kinase (IU/L) test.
- Bangsbo sprint test [ Time Frame: During the performance protocol and fatigue performed once a week for four weeks. ]To quantify the performance of rugby players in the Bangsbo sprint test (seconds).
- Yo-Yo Intermittent Recovery Test [ Time Frame: During the performance protocol and fatigue performed once a week for four weeks. ]To quantify the performance of rugby players in the Yo-Yo Intermittent Recovery Test (meters).
- Functional performance in the Star Excursion Balance Test [ Time Frame: Before, immediately after and after 48 hours. ]Measure the distance (centimeters) reached with each lower limb in the Star Excursion Balance Test modified.
- Functional performance in Single Hop Test and Triple Hop Test [ Time Frame: Before, immediately after and after 48 hours. ]Measure the distance (centimeters) reached with each lower limb in the Single Hop Test and in the Triple Hop Test.
- Recovery and psychophysiological stress [ Time Frame: 48 hours after performance tests ]Will be applied the questionnaire Recovery-Stress Questionnaire for Athletes translated and validated for Portuguese language with the objective of evaluating recovery and psychophysiological stress. Consists of 19 scales (General Stress, Emotional Stress, Social Stress, Conflicts / Pressure, Fatigue, Lack of Energy, Complaints Somatic, Success, Social Recovery, Physical Recovery, General Welfare, Sleep Quality, Intervals, Emotional Exhaustion, Injuries, Fitness, Self Acceptance, Self-Efficacy and Self-Regulation), with four questions on each scale, totaling 76 questions. The values of the scales are calculated by the mean values of the items, which can vary from 0 to 6. High scores on the scales associated with stress activities reflect intense subjective stress, while high scores on the scales associated with recovery reflect many recovery activities.
- Changes in blood lactate [ Time Frame: Before, immediately after the second Yoyo IR1 and 10 minutes after the end of this test. ]Analysis of effort intensity during performance tests
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 35 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Individuals practicing rugby;
- Juvenile and adult categories;
- Minimum training of three days per week;
- Without history of musculoskeletal injuries in the lower limbs in the last year;
- Without the use of supplements or medicines.
Exclusion Criteria:
- Injuries that make it impossible to perform the tests.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03728439
| Brazil | |
| University Hospital of the State University of Londrina | |
| Londrina, Paraná, Brazil, 86038-350 | |
| Principal Investigator: | Christiane Macedo | State University of Londrina |
| Responsible Party: | Universidade Estadual de Londrina |
| ClinicalTrials.gov Identifier: | NCT03728439 |
| Other Study ID Numbers: |
Recovery in rugby athletes |
| First Posted: | November 2, 2018 Key Record Dates |
| Last Update Posted: | July 13, 2021 |
| Last Verified: | July 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Recovery Rugby Phototherapy |

